44P BOLD-100-001: A Phase II Study of BOLD-100 in Combination with FOLFOX in Advanced Mcrc Patients That Have Failed at Least Two Prior Lines of Therapy

G.M. O'Kane,J. Spratlin, D-Y. Oh,S.Y. Rha,E. McWhirter,E. Elimova,P. Kavan, M.K. Choi, D. Kim,R.A. Goodwin,J.R. Hecht,D-H. Koo, K. Halani, R. McAllister, M. Jones, M.D. Snow, Y. Lemmerick, G. Spera, J. Pankovich

Annals of Oncology（2024）

Cited 0|Views3

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined